Brio Capital Master Fund Ltd. 13D/13G Filings for Sigyn Therapeutics, Inc. (SIGY)

Brio Capital Master Fund Ltd. 13D and 13G filings for Sigyn Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2025-02-14
5:38 pm
Purchase		 2024-11-19 13G Sigyn Therapeutics, Inc.
SIGY		 Brio Capital Master Fund Ltd. 158,932
9.990%		 36,828increase
(+30.16%)		 Filing
2024-02-08
12:48 pm
Purchase		 2024-01-09 13G Sigyn Therapeutics, Inc.
SIGY		 Brio Capital Master Fund Ltd. 122,104
9.990%		 122,104increase
(New Position)		 Filing